Meet some of the consumers touched by our programs
"The triple-agonist design of Retatrutide offers an unprecedented mechanism of action, targeting multiple synergetic metabolic pathways to optimize energetic homeostasis in laboratory models." Preclinical in-vitro models indicate that GIP and GLP-1 receptor activations synergistically stimulate glucose-dependent insulin secretion, while glucagon receptor activation increases cellular energy expenditure and fatty acid oxidation
Alluvi Retatrutide 20mg Pen is a research-grade triple-agonist peptide formulation examined for metabolic pathway interaction and endocrine signalling behaviour in controlled laboratory settings
Ozempic is a specific brand of GLP-1 receptor agonist used to manage type 2 diabetes and obesity
The drug slows stomach emptying which helps control your appetite by making you feel fuller for longer
Without sufficient glutathione, the detoxification burden can manifest as fatigue, headaches, brain fog, and the general malaise that some patients attribute to the medication itself